Public assurance
Product boundaries, operating principles, current claims and prospect FAQs that can be reviewed without an NDA.
- Public experience with fixture data
- Human authority boundary
- No certification claims
- Diligence route visible
Tenvia Trust Centre
Review the controls before you buy.
Sponsors and CROs can review our position on security, privacy, clinical quality and AI governance before starting formal due diligence.
01
Public experience with fixture dataNo production clinical data in this workspace.
02Human authority retainedNo autonomous clinical or commercial approval.
03Claims stated preciselyNo claim of certification or agency approval.
04Evidence disclosed responsiblyPublic, contractual and controlled assurance stay distinct.
Assurance model
The right evidence, at the right stage.
Public controls are available to every prospect. Sensitive technical and quality evidence is shared through a controlled review.
Assurance library
Every diligence lens, in one place.
Each area states the public position, the production boundary and the evidence available for controlled review.
Claims boundary
Confidence begins with precision.
Tenvia separates public principles, contractual controls and sensitive evidence so buyers can understand the current position without guesswork. Certifications and independent reports are published only when achieved, current and applicable to the service.
Security and diligence
Request the right level of access.
Start with a public product review. Add confidentiality when the discussion includes sensitive study or security information.
How access works
01Explore publiclyReview the product using fixture data. No NDA is required.02Discuss confidentiallyPut a mutual NDA in place before sharing study material.03Review evidenceReceive controlled access to the relevant assurance material.
Access is granted only after Tenvia confirms the request, confidentiality route and available evidence.